INVESCO Health Care Fund
Fund
GGHCX
Price as of:
$38.92
+ $0.40
+ 1.04%
Primary Theme
fund company
Name
As of 11/20/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
7.7%
1 yr return
14.3%
3 Yr Avg Return
-0.2%
5 Yr Avg Return
6.0%
Net Assets
$1.35 B
Holdings in Top 10
46.7%
52 WEEK LOW AND HIGH
$38.5
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 1.06%
SALES FEES
Front Load 5.50%
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
$250
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 11/20/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
GGHCX - Profile
Distributions
- YTD Total Return 7.7%
- 3 Yr Annualized Total Return -0.2%
- 5 Yr Annualized Total Return 6.0%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.24%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameINVESCO Health Care Fund
-
Fund Family NameInvesco
-
Inception DateAug 07, 1989
-
Shares OutstandingN/A
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerJustin Livengood
GGHCX - Performance
Return Ranking - Trailing
| Period | GGHCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 7.7% | -29.1% | 19.1% | 33.96% |
| 1 Yr | 14.3% | -17.5% | 44.4% | 51.57% |
| 3 Yr | -0.2%* | -30.1% | 8.6% | 56.58% |
| 5 Yr | 6.0%* | -7.8% | 11.8% | 69.86% |
| 10 Yr | 4.2%* | 0.0% | 13.1% | 84.68% |
* Annualized
Return Ranking - Calendar
| Period | GGHCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 3.9% | -12.6% | 19.0% | 33.96% |
| 2022 | -13.5% | -53.9% | 3.2% | 63.82% |
| 2021 | -10.7% | -39.6% | 24.2% | 74.34% |
| 2020 | 7.4% | -13.6% | 178.2% | 74.50% |
| 2019 | 27.4% | 3.8% | 63.8% | 15.04% |
Total Return Ranking - Trailing
| Period | GGHCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 7.7% | -29.1% | 19.1% | 33.96% |
| 1 Yr | 14.3% | -17.5% | 44.4% | 51.57% |
| 3 Yr | -0.2%* | -30.1% | 8.6% | 56.58% |
| 5 Yr | 6.0%* | -7.8% | 11.8% | 69.86% |
| 10 Yr | 4.2%* | 0.0% | 13.1% | 84.68% |
* Annualized
Total Return Ranking - Calendar
| Period | GGHCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 3.9% | -12.6% | 19.0% | 54.09% |
| 2022 | -13.5% | -53.9% | 3.7% | 75.66% |
| 2021 | 12.2% | -33.9% | 26.0% | 32.24% |
| 2020 | 14.4% | -0.7% | 180.6% | 76.51% |
| 2019 | 31.8% | 4.6% | 63.8% | 23.31% |
NAV & Total Return History
GGHCX - Holdings
Concentration Analysis
| GGHCX | Category Low | Category High | GGHCX % Rank | |
|---|---|---|---|---|
| Net Assets | 1.35 B | 6.66 M | 45.7 B | 37.11% |
| Number of Holdings | 80 | 25 | 430 | 50.94% |
| Net Assets in Top 10 | 643 M | 2.12 M | 22.1 B | 34.59% |
| Weighting of Top 10 | 46.65% | 18.4% | 79.7% | 51.57% |
Top 10 Holdings
- Eli Lilly and Co. 8.50%
- Boston Scientific Corp. 5.80%
- UnitedHealth Group Inc. 5.23%
- McKesson Corp. 4.28%
- Danaher Corp. 4.24%
- Vertex Pharmaceuticals Inc. 3.89%
- Intuitive Surgical, Inc. 3.82%
- Merck Co., Inc. 3.72%
- AstraZeneca PLC, ADR 3.63%
- Regeneron Pharmaceuticals, Inc. 3.56%
Asset Allocation
| Weighting | Return Low | Return High | GGHCX % Rank | |
|---|---|---|---|---|
| Stocks | 96.52% | 87.34% | 106.13% | 80.50% |
| Cash | 7.61% | 0.00% | 33.01% | 12.58% |
| Preferred Stocks | 0.00% | 0.00% | 7.86% | 66.04% |
| Other | 0.00% | -22.99% | 23.24% | 69.18% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 53.25% |
| Bonds | 0.00% | 0.00% | 12.39% | 64.15% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | GGHCX % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 59.26% | 100.00% | 27.92% |
| Utilities | 0.00% | 0.00% | 0.00% | 50.00% |
| Technology | 0.00% | 0.00% | 22.69% | 53.90% |
| Real Estate | 0.00% | 0.00% | 5.89% | 52.60% |
| Industrials | 0.00% | 0.00% | 7.02% | 53.90% |
| Financial Services | 0.00% | 0.00% | 1.60% | 66.88% |
| Energy | 0.00% | 0.00% | 0.00% | 50.00% |
| Communication Services | 0.00% | 0.00% | 9.11% | 53.25% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 55.84% |
| Consumer Cyclical | 0.00% | 0.00% | 1.92% | 52.60% |
| Basic Materials | 0.00% | 0.00% | 7.16% | 66.88% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | GGHCX % Rank | |
|---|---|---|---|---|
| US | 91.08% | 66.06% | 104.41% | 57.86% |
| Non US | 5.43% | 0.00% | 28.87% | 40.25% |
GGHCX - Expenses
Operational Fees
| GGHCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.06% | 0.08% | 4.48% | 51.57% |
| Management Fee | 0.63% | 0.03% | 1.25% | 37.11% |
| 12b-1 Fee | 0.25% | 0.00% | 1.00% | 40.26% |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| GGHCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | 5.50% | 3.50% | 5.75% | 62.50% |
| Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
| GGHCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| GGHCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | 0.00% | 238.00% | 11.95% |
GGHCX - Distributions
Dividend Yield Analysis
| GGHCX | Category Low | Category High | GGHCX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 6.24% | 67.92% |
Dividend Distribution Analysis
| GGHCX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annual | Annual | Annual | Annual |
Net Income Ratio Analysis
| GGHCX | Category Low | Category High | GGHCX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.24% | -2.54% | 1.85% | 50.00% |
Capital Gain Distribution Analysis
| GGHCX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 16, 2021 | $9.930 | CapitalGainLongTerm |
| Dec 15, 2020 | $2.899 | OrdinaryDividend |
| Dec 13, 2019 | $0.103 | OrdinaryDividend |
| Dec 13, 2019 | $1.370 | CapitalGainLongTerm |
| Dec 14, 2018 | $0.113 | CapitalGainShortTerm |
| Dec 14, 2018 | $2.790 | CapitalGainLongTerm |
| Dec 13, 2017 | $2.448 | CapitalGainLongTerm |
| Dec 13, 2016 | $0.737 | CapitalGainLongTerm |
| Dec 13, 2016 | $0.075 | OrdinaryDividend |
| Dec 12, 2014 | $0.007 | CapitalGainShortTerm |
| Dec 12, 2014 | $4.924 | CapitalGainLongTerm |
| Dec 13, 2013 | $0.235 | CapitalGainShortTerm |
| Dec 13, 2013 | $3.220 | CapitalGainLongTerm |
| Dec 13, 2013 | $0.013 | OrdinaryDividend |
| Sep 19, 2013 | $0.051 | OrdinaryDividend |
| Dec 07, 2012 | $2.241 | CapitalGainLongTerm |
| Dec 07, 2012 | $0.123 | OrdinaryDividend |
| Dec 09, 2011 | $0.144 | OrdinaryDividend |
| Dec 09, 2011 | $0.483 | CapitalGainLongTerm |
| Dec 12, 2008 | $0.601 | CapitalGainLongTerm |
| Dec 14, 2007 | $0.715 | CapitalGainShortTerm |
| Dec 14, 2007 | $2.166 | CapitalGainLongTerm |
| Dec 15, 2006 | $3.002 | CapitalGainLongTerm |
| Dec 16, 2005 | $0.934 | CapitalGainLongTerm |
| Dec 14, 2001 | $1.547 | CapitalGainShortTerm |
| Dec 14, 2001 | $2.511 | CapitalGainLongTerm |
| Dec 14, 2000 | $1.136 | CapitalGainShortTerm |
| Dec 14, 2000 | $2.108 | CapitalGainLongTerm |
| Dec 15, 1999 | $2.283 | CapitalGainLongTerm |
GGHCX - Fund Manager Analysis
Managers
Justin Livengood
Start Date
Tenure
Tenure Rank
Dec 18, 2020
1.45
1.5%
Mr. Livengood has been a Vice President of OppenheimerFunds since May 2006 and a Senior Portfolio Manager since January 2014. He was a Senior Research Analyst from May 2006 to January 2014, responsible for the health care, energy and financial services sectors for mid- and small-cap growth accounts. Before joining OppenheimerFunds in May 2006, Mr. Livengood was a vice president and fund analyst with Merrill Lynch Investment Managers. During his tenure at Merrill Lynch he also worked as an investment banking analyst in the Global Media Group and as an associate with Merrill Lynch Ventures.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 7.88 | 0.25 |